Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
VIDYA RAMAKRISHNAN

Analysts See Silver Lining For These Three Stocks Amid Trump Tariff Gloom

Tariff uncertainty has investors worrying whether a cloud hangs over the outlook for corporate profits, making stocks with rising profit estimates all the more notable. Two China stocks, Atour Lifestyle Holdings and Futu Holdings, are setting up near buy points while analysts also expect their profits to rise.

Both are in the IBD 50 growth stocks list.

Investor's Business Daily's screener for stocks with rising profit estimates also shows insurance stock EverQuote near a buy point.

Build Your Watchlist With Customized Stock Screens

EverQuote provides an online marketplace for insurance products. Shares gapped up 27% after fourth quarter results on Feb. 25 and are in a cup with handle base with a buy point of 26.99.

EverQuote's Composite Rating is an ideal 99 while the Relative Strength Rating is also strong at 96. While the EPS Rating meets recommended levels of 80, earnings are seen rising 36% in 2025 to $1.20 per share. In 2026, earnings estimates of $1.31 per share suggests a 9% increase in profits.

Funds have been net buyers over the past 13 weeks, giving the stock an Accumulation/Distribution Rating of B-.

Futu Stock Sets Up With Rising Profits Estimates

One of two China stocks, Atour has rallied ahead of fourth quarter results on March 25 and is at the top of a buy zone from a buy point of 29.90. The Shanghai-based hotel firm also holds a near-ideal Composite Rating of 97 and Relative Strength Rating of 96. The EPS Rating is a best-possible 99. Analysts see profits rising 34% to 54 cents per share in 2025.

Atour holds an Accumulation/Distribution Rating of A-.

Meanwhile, Futu stock is approaching a handle buy point of 130.88 in a cup base. The stock holds a Composite Rating of 99 while its Earnings Per Share and Relative Strength ratings stand at 98. Futu provides an online brokerage platform.

Analysts see earnings per share increasing 18% to $8.30 in 2026 while in the current year, estimates call for a 38% increase in earnings to $7.04 per share.

Best IBD 50 Stocks To Watch

More funds have been adding the stock to their portfolios over the past five quarters. The Accumulation/Distribution Rating of B+ also indicates strong interest from funds over the past 13 weeks.

Please follow VRamakrishnan on X/Twitter for more news on the stock market today.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.